Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_716e9a2606ffd4ba1a2a3917e4a402fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_baa68883fbe199cfbdd779342b0d0c6f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2033-4975 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
filingDate |
2016-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c52b064d3d80a9be7a8b5507803f5ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8f3aab369e2ab610f5fd14e680e7fd7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d53eeaec664f6888357ecf5eefb8ceab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_723ca863685fcc1e694457bd55a70299 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d1b49c26ca18386472251e6aba23d06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db74c29b3783656250cc3e59c4a66327 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc0310c69a072889ed2bf47107beda0b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70f9534b4022fb6a37c0b21fdf2822e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a68cfe47f0728b8ee4ebfec1f088835 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52fabc48d80d1568f34cd3da3b5bca60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cec3c23232ddeed8f94a33a11f078fb8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3d0e7d0305326d87e56401f4e190f4d |
publicationDate |
2019-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3557250-A1 |
titleOfInvention |
Cancer development risk assessment device, program, and method for testing cancer development risk |
abstract |
Provided is a cancer development risk assessment method capable of determining the possibility of cancer development in a subject to be assessed in short time. The cancer development risk assessment method measures concentrations of a plurality of types of target components included in exhaled air collected from a subject to be assessed. An assessment score correlated to the possibility of cancer being developed in the subject to be assessed is calculated based on measurement results of the concentrations obtained. |
priorityDate |
2015-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |